January 11, 2017: Here are four stocks trading with relatively heavy volume among 25 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by more than 2 to 1 and on the Nasdaq advancers led decliners by about 7 to 6.
DryShips Inc. (NASDAQ: DRYS) dropped about 11.4% on Wednesday to post a new 52-week low of $2.34 against a 52-week high of $278.40 and a Tuesday close of $2.73. Volume of about 15 million was 80% higher than the daily average of around 8.5 million. Investors continue to run away from the company’s diversification in LPG shipping.
Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped about 4.7% on Wednesday to post a new 52-week low of $3.24 after closing at $3.40 on Tuesday. Volume was about 4 times the daily average of about 3.9 million shares. The stock’s 52-week high is $9.02 The company said Tuesday that it has sold some of its cancer drugs to Ipsen for $1 billion.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) dropped about 4.7% Wednesday to post a new 52-week low of $33.56 after closing Tuesday at $35.20. The 52-week high is $65.20. Volume of around 13.4 million was about 35% above the daily average of around 10 million shares traded. At his press conference Wednesday, President-elect Trump drew a big target on high drug prices.
Macy’s Inc. (NYSE: M) dropped about 1.8% Wednesday, posting a new 52-week low of $29.75 after closing at $30.30 on Tuesday. The stock’s 52-week high is $45.50. The department store retailer had no specific news.
Are You Ahead, or Behind on Retirement? (sponsor)
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.